Journal
AMERICAN JOURNAL OF NEURORADIOLOGY
Volume 31, Issue 4, Pages 626-627Publisher
AMER SOC NEURORADIOLOGY
DOI: 10.3174/ajnr.A2054
Keywords
-
Ask authors/readers for more resources
Cetuximab, a recombinant chimeric monoclonal antibody, has been successfully used in the treatment of the head and neck and colorectal cancers. We present a review of its mechanism of action, indications, side effects and economic issues, accompanied by a clinical example from our institution.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
